Targeting the PD-1/PD-L1 Axis in Human Vitiligo
Autoreactive CD8+ T cells play a pivotal role in melanocyte destruction in autoimmune vitiligo. Immunotherapy for melanoma often leads to autoimmune side-effects, among which vitiligo-like depigmentation, indicating that targeting immune checkpoints can break peripheral tolerance against self-antige...
Main Authors: | Marcella Willemsen, Cornelis J. M. Melief, Marcel W. Bekkenk, Rosalie M. Luiten |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.579022/full |
Similar Items
-
MART-1 transcript is absent in PBMCs from Vitiligo patients
by: Bam Marpe, et al.
Published: (2009-12-01) -
Childhood vitiligo: A clinicoepidemiological study
by: Mrinal Gupta
Published: (2018-01-01) -
Vitiligo na infância: características clínicas e epidemiológicas Childhood vitiligo: clinical and epidemiological characteristics
by: Cláudia Márcia de Resende Silva, et al.
Published: (2007-02-01) -
PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective
by: HaiXia Li, et al.
Published: (2021-07-01) -
Polymorphisms in the Melanocortin-1 Receptor (Mc1R) Gene in Vitiligo
by: Eylem Acar, et al.
Published: (2012-03-01)